Unique market dynamics and plenty of exit options are attracting investors to dermatology. New products and business models are evolving because of technology and the times we live in.
Aclaris Therapeutics Inc. is developing a topical treatment for seborrheic keratosis, a type of benign growth typically described as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?